Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
SENOMYX INC (0001123979)
Standardized SEC financial data for SENOMYX INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001123979 · Services-Commercial Physical & Biological Research.
Operating margin
-5.4%
Net margin
-43.0%
Revenue growth (YoY)
-10.1%
Return on equity
-57.0%
Free cash flow
$1.5M
Current ratio
4.57×
Ratios for fiscal year 2015, standardized from SEC filings.
Income statement
USD
FY2016
FY2017
R&D expense
$19.3M
$15.0M
SG&A expense
$11.8M
$12.1M
Operating income
-$10.8M
-$1.3M
Net income
-$10.7M
—
Standardized from SENOMYX INC's SEC filings — per-share figures split-adjusted. Full history via the API.